{"entity":{"type":"insider","cik":"0001700917","url":"/insider/0001700917","json_url":"/insider/0001700917.json","name":"Dugel Pravin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2021-04-05","last":"2026-05-28","span_basis":"filed_date"},"name_variants":[{"name":"Dugel Pravin","source":"filing","n_filings":11,"first_seen":"2021-04-05","last_seen":"2026-05-28"}],"transactions":[{"id":5835545,"accession":"0001104659-26-067485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-067485","line_url":"/filing/0001104659-26-067485#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21156.0,"shares_display":"21,156","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":173479.2,"total_display":"173,479.20","total_whole":"173,479","shares_owned_after":2597170.0,"shares_owned_after_display":"2,597,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-26","filed_date":"2026-05-28","scope":"insider"},{"id":5903486,"accession":"0001104659-26-019805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-019805","line_url":"/filing/0001104659-26-019805#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20056.0,"shares_display":"20,056","price_per_share":8.28,"price_display":"8.28","price_state":"stated","total_value":166063.68,"total_display":"166,063.68","total_whole":"166,064","shares_owned_after":3013022.0,"shares_owned_after_display":"3,013,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":5956598,"accession":"0001104659-26-016666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-016666","line_url":"/filing/0001104659-26-016666#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124882.0,"shares_display":"124,882","price_per_share":9.04,"price_display":"9.04","price_state":"stated","total_value":1128933.28,"total_display":"1,128,933.28","total_whole":"1,128,933","shares_owned_after":3033078.0,"shares_owned_after_display":"3,033,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-17","scope":"insider"},{"id":4064613,"accession":"0001104659-25-116424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-116424","line_url":"/filing/0001104659-25-116424#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19530.0,"shares_display":"19,530","price_per_share":12.04,"price_display":"12.04","price_state":"stated","total_value":235141.2,"total_display":"235,141.20","total_whole":"235,141","shares_owned_after":3157960.0,"shares_owned_after_display":"3,157,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":5129074,"accession":"0001104659-25-084113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-084113","line_url":"/filing/0001104659-25-084113#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21494.0,"shares_display":"21,494","price_per_share":12.04,"price_display":"12.04","price_state":"stated","total_value":258787.76,"total_display":"258,787.76","total_whole":"258,788","shares_owned_after":3227244.0,"shares_owned_after_display":"3,227,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-27","scope":"insider"},{"id":4199005,"accession":"0001104659-25-053087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-053087","line_url":"/filing/0001104659-25-053087#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21219.0,"shares_display":"21,219","price_per_share":7.18,"price_display":"7.18","price_state":"stated","total_value":152352.42,"total_display":"152,352.42","total_whole":"152,352","shares_owned_after":3499099.0,"shares_owned_after_display":"3,499,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-23","filed_date":"2025-05-27","scope":"insider"},{"id":4111466,"accession":"0001104659-25-017568","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-017568","line_url":"/filing/0001104659-25-017568#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21475.0,"shares_display":"21,475","price_per_share":6.87,"price_display":"6.87","price_state":"stated","total_value":147533.25,"total_display":"147,533.25","total_whole":"147,533","shares_owned_after":3520318.0,"shares_owned_after_display":"3,520,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-26","scope":"insider"},{"id":2238482,"accession":"0001104659-24-123407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-123407","line_url":"/filing/0001104659-24-123407#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20680.0,"shares_display":"20,680","price_per_share":9.01,"price_display":"9.01","price_state":"stated","total_value":186326.8,"total_display":"186,326.80","total_whole":"186,327","shares_owned_after":791793.0,"shares_owned_after_display":"791,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-27","scope":"insider"},{"id":2284736,"accession":"0001104659-24-093500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-093500","line_url":"/filing/0001104659-24-093500#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20880.0,"shares_display":"20,880","price_per_share":9.02,"price_display":"9.02","price_state":"stated","total_value":188337.6,"total_display":"188,337.60","total_whole":"188,338","shares_owned_after":812473.0,"shares_owned_after_display":"812,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-27","scope":"insider"},{"id":2963383,"accession":"0001104659-24-065644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-065644","line_url":"/filing/0001104659-24-065644#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21626.0,"shares_display":"21,626","price_per_share":5.79,"price_display":"5.79","price_state":"stated","total_value":125214.54,"total_display":"125,214.54","total_whole":"125,215","shares_owned_after":833353.0,"shares_owned_after_display":"833,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-23","filed_date":"2024-05-28","scope":"insider"},{"id":5536008,"accession":"0001104659-21-046743","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-046743","line_url":"/filing/0001104659-21-046743#line-3","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"IVERIC bio, Inc.","issuer_ticker":"ISEE","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001700917","owner_name":"Dugel Pravin","owner_display_name":"Dugel Pravin","owner_url":"/insider/0001700917","role":"Officer (EVP, Chief Strategy & Business)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy & Business)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy & Business","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28301.0,"shares_display":"28,301","price_per_share":6.34,"price_display":"6.34","price_state":"stated","total_value":179428.34,"total_display":"179,428.34","total_whole":"179,428","shares_owned_after":41699.0,"shares_owned_after_display":"41,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Director, Officer","n_filings":10,"first_seen":"2024-05-28","last_seen":"2026-05-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001410939","name":"IVERIC bio, Inc.","url":"/issuer/0001410939","role":"Officer (EVP, Chief Strategy & Business)","n_filings":1,"first_seen":"2021-04-05","last_seen":"2021-04-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001700917","retrieved_at":"2026-08-25T14:29:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}